Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | May 05, 2020 | May 07, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date May 05, 2020 · Filed May 07, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,052 |
Reported balance
After 2020-05-05 transaction · row 1
1 source rowRow 1 · 2020-05-05 · Exercise / conversion · Acquired 2,270 · Balance 129,052 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-05-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-05 · Exercise / conversion · Disposed 2,270 · Balance 0 F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: 100% of the restricted stock units vested on May 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: 100% of the restricted stock units vested on May 5, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · derivative · entry 28 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,600 Underlying: Common Stock · 100,000 shares Expires 2011-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options vest 5% quarterly over five years beginning from date of grant. The option was fully vested as of October 25, 2006. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $82.93 | $49,758.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 27 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,582 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,400 | $82.92 | $199,008.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 26 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,182 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 900 | $82.91 | $74,619.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 25 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,582 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 4,200 | $82.90 | $348,180.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 24 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,482 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $82.89 | $8,289.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 23 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,682 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 4,600 | $82.88 | $381,248.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 22 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,782 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $82.87 | $58,009.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 21 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,382 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,500 | $82.86 | $124,290.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 20 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,082 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 400 | $82.85 | $33,140.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 19 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,582 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 360 | $82.84 | $29,822.40 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 18 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,982 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 4,658 | $82.83 | $385,822.14 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 17 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,342 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 6,000 | $82.83 | $496,980.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 16 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 342 | $82.83 | $28,327.86 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 15 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 200 | $82.82 | $16,564.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 14 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,342 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 100 | $82.81 | $8,281.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 13 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,542 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,900 | $82.80 | $157,320.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 12 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,642 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 130 | $82.79 | $10,762.70 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 11 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,542 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 230 | $82.78 | $19,039.40 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 10 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,672 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,300 | $82.77 | $190,371.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 9 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,902 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,600 | $82.76 | $132,416.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 8 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,202 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 19,448 | $82.75 | $1,609,322.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,802 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 18,000 | $82.75 | $1,489,500.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,250 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 100,000 | $17.16 | $1,716,250.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 30,000 | $57.35 | $1,720,500.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 6,000 | $57.36 | $344,160.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 26,250 | $38.87 | $1,020,337.50 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:04 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 18,000 | $16.25 | $292,410.00 |
DisclosureSEC source: 0001179110-07-011147 · edgar.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 700 | $83.00 | $58,100.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 800 | $82.99 | $66,392.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,700 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 600 | $82.98 | $49,788.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,500 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 682 | $82.97 | $56,585.54 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,100 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 3,200 | $82.96 | $265,472.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,782 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 2,100 | $82.95 | $174,195.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 2 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,982 Read SEC document |
| May 21, 2007 Filed May 24, 2007 00:05 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 1,500 | $82.94 | $124,410.00 |
DisclosureSEC source: 0001179110-07-011148 · edgar.xml · nonDerivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,082 Read SEC document |
| May 09, 2007 Filed May 11, 2007 23:06 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $82.82 | $0.00 |
DisclosureSEC source: 0001179110-07-009843 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2017-05-09 F1 · derivative.exercise_date: Options vested in full on May 9, 2007, the date of grant. Read SEC document |
| July 03, 2006 Filed Jul 6, 2006 18:09 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 506.24 | $59.26 Strike: $59.26 | $29,999.78 |
DisclosureSEC source: 0001179110-06-014738 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506.24 Underlying: Common Stock · 506.24 shares Expires not disclosed F1 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock over five years when the reporting person reaches the age of 65. F1 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock over five years when the reporting person reaches the age of 65. Read SEC document |
| May 10, 2006 Filed May 12, 2006 00:47 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001179110-06-010652 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2016-05-10 F1 · kind: Options are granted as part of the annual compensation to non-employee members of the Board of Directors and are immediately exercisable on date of grant. Read SEC document |
| January 26, 2006 Filed Jan 28, 2006 00:52 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $57.36 | $0.00 |
DisclosureSEC source: 0001179110-06-002222 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2016-01-26 F1 · derivative.exercise_date: Options are 100% vested on date of grant. Read SEC document |
| July 01, 2005 Filed Jul 6, 2005 21:55 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantPhantom Stock · Derivative | 1,359.62 | $44.13 Strike: $44.13 | $60,000.03 |
DisclosureSEC source: 0001179110-05-013882 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,359.62 Underlying: Common Stock · 1,359.62 shares Expires not disclosed F1 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable over five years when the reporting person reaches the age of 65. F1 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable over five years when the reporting person reaches the age of 65. Read SEC document |
| May 10, 2005 Filed May 12, 2005 20:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 26,250 | $0.00 Strike: $38.87 | $0.00 |
DisclosureSEC source: 0001179110-05-009692 · edgar.xml · derivative · entry 1 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Common Stock · 26,250 shares Expires 2015-05-10 Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 42,000 | $0.00 Strike: $31.40 | $0.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · derivative · entry 11 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,000 shares Expires 2014-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options are fully vested on date of grant. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $28.50 | $0.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · derivative · entry 10 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2014-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Options are fully vested on date of grant. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $29.21 | $0.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · derivative · entry 9 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2013-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vested 100% on the anniversary date of the grant provided that there was no interruption to continuous service prior to vest date. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · derivative · entry 8 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,600 Underlying: Common Stock · 10,000 shares Expires 2011-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vest quarterly in twenty equal installments over a five year period, beginning three months from the date of grant. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,800 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · derivative · entry 7 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,600 Underlying: Common Stock · 10,800 shares Expires 2012-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vest quarterly in twenty equal installments over a five year period, beginning three months from the date of grant. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | SaleCommon Stock | 104,800 | $34.52 | $3,617,255.84 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · nonDerivative · entry 6 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 42,000 | $31.40 | $1,318,800.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · nonDerivative · entry 5 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 6,000 | $28.50 | $171,000.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · nonDerivative · entry 4 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2004 Filed Nov 23, 2004 22:44 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 36,000 | $29.21 | $1,051,380.00 |
DisclosureSEC source: 0001179110-04-021996 · edgar.xml · nonDerivative · entry 3 WILSON GAYLE E · CIK 0001198227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.